Form 4: Edwards Lifesciences Executive Daniel J. Lippis Reports Stock Disposal
SEC Form 4 Filing
Daniel J. Lippis, CVP of JAPAC at Edwards Lifesciences, reported the disposal of 410 shares of common stock at a price of $92.32 on July 7, 2024.
Summary
- On July 7, 2024, Daniel J. Lippis, CVP of JAPAC at Edwards Lifesciences Corp, disposed of 410 shares of common stock at $92.32 per share.
- Following the transaction, Lippis directly owns 23,189.0651 shares of Edwards Lifesciences common stock.
- The transaction was reported on a Form 4 filing with the SEC on July 8, 2024.
Sentiment
Score: 5
Explanation: Neutral sentiment as it's a standard disclosure of stock disposal by an executive. The transaction itself doesn't necessarily indicate a positive or negative outlook.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. The sale could be for personal financial planning reasons and may not reflect a negative outlook on the company.
Stakeholder Impact
- The transaction may have a minor impact on shareholders due to the transparency provided by the Form 4 filing.
Key Dates
| Date | Description |
|---|---|
| 07/07/2024 | Date of stock disposal transaction |
| 07/08/2024 | Date of Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.